BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3314259)

  • 21. Taxonomic relationships among Clostridium novyi Types A and B, Clostridium haemolyticum and Clostridium botulinum type C.
    Nakamura S; Kimura I; Yamakawa K; Nishida S
    J Gen Microbiol; 1983 May; 129(5):1473-9. PubMed ID: 6352856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative molecular topography of botulinum neurotoxins from Clostridium butyricum and Clostridium botulinum type E.
    Singh BR; Giménez JA; DasGupta BR
    Biochim Biophys Acta; 1991 Mar; 1077(1):119-26. PubMed ID: 1901221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic hemagglutination inhibition test in examining of the culture supernatants of Clostridium botulinum types A, B, E, and F and some related bacterial species.
    Reiss J; Wojtyła B; Lipko A
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):531-9. PubMed ID: 6200089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile.
    Heard SR; Rasburn B; Matthews RC; Tabaqchali S
    J Clin Microbiol; 1986 Sep; 24(3):384-7. PubMed ID: 2428826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noncorrelation between mouse toxicity and serologically assayed toxin in Clostridium botulinum type A culture fluids.
    Betley MJ; Sugiyama H
    Appl Environ Microbiol; 1979 Aug; 38(2):297-300. PubMed ID: 391153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium sporogenes isolates and their relationship to C. botulinum based on deoxyribonucleic acid reassociation.
    Nakamura S; Okado I; Nakashio S; Nishida S
    J Gen Microbiol; 1977 Jun; 100(2):395-401. PubMed ID: 330814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sensitive and useful radioimmunoassay for neurotoxin and its haemagglutinin complex from Clostridium botulinum.
    Ashton AC; Crowther JS; Dolly JO
    Toxicon; 1985; 23(2):235-46. PubMed ID: 3895579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Problem of non-soluble antigens in the identification of Cl. botulinum. I. Precipitation and immunofluorescence studies].
    Cygan Z
    Pol Arch Weter; 1972; 15(2):245-64. PubMed ID: 4572437
    [No Abstract]   [Full Text] [Related]  

  • 30. Purification and immunochemical properties of a wall protein antigen from Clostridium difficile ATCC 11011.
    Takumi K; Takeoka A; Kawata T
    Microbiol Immunol; 1987; 31(9):837-49. PubMed ID: 3320689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and characterization of a protease from Clostridium botulinum type A that nicks single-chain type A botulinum neurotoxin into the di-chain form.
    Dekleva ML; Dasgupta BR
    J Bacteriol; 1990 May; 172(5):2498-503. PubMed ID: 2185224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New strains of Clostridium botulinum subtype Af.
    Giménez DF; Ciccarelli AS
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):215-20. PubMed ID: 77604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological studies of Clostridium botulinum type E and related organisms.
    Lynt RK; Solomon HM; Kautter DA; Lilly T
    J Bacteriol; 1967 Jan; 93(1):27-35. PubMed ID: 5335894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan.
    Kozaki S; Nakaue S; Kamata Y
    Microbiol Immunol; 1995; 39(10):767-74. PubMed ID: 8577267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the botulinum neurotoxin type F gene clusters in proteolytic and nonproteolytic Clostridium botulinum and Clostridium barati.
    East AK; Bhandari M; Hielm S; Collins MD
    Curr Microbiol; 1998 Oct; 37(4):262-8. PubMed ID: 9732534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similarity in the EDTA-soluble antigens of Clostridium chauvoei and C. septicum.
    Hamaoka T; Mori Y; Terakado N; Nakamura S
    J Gen Microbiol; 1993 Mar; 139(3):617-22. PubMed ID: 8473867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of Clostridium botulinum type E from soil of Gwalior, India.
    Dhaked RK; Sharma SK; Parida MM; Singh L
    J Nat Toxins; 2002 Feb; 11(1):49-56. PubMed ID: 11829060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):220-7. PubMed ID: 3293334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the spore surface and exosporium proteins of Clostridium sporogenes; implications for Clostridium botulinum group I strains.
    Janganan TK; Mullin N; Tzokov SB; Stringer S; Fagan RP; Hobbs JK; Moir A; Bullough PA
    Food Microbiol; 2016 Oct; 59():205-12. PubMed ID: 27375261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophoretic study of Clostridium species.
    Cato EP; Hash DE; Holdeman LV; Moore WE
    J Clin Microbiol; 1982 Apr; 15(4):688-702. PubMed ID: 6175658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.